Antdorf, Germany

Rebecca Croasdale

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 8.3

ph-index = 5

Forward Citations = 139(Granted Patents)


Company Filing History:


Years Active: 2014-2024

where 'Filed Patents' based on already Granted Patents

8 patents (USPTO):

Title: Celebrating the Innovations of Inventor Rebecca Croasdale

Introduction

Rebecca Croasdale, an accomplished inventor based in Antdorf, Germany, has made significant contributions to the field of biotechnology. With a remarkable portfolio of eight patents, her work primarily revolves around the development of innovative antibody technologies. Her inventions have considerable implications in the pharmaceutical industry, paving the way for advanced therapeutic options.

Latest Patents

Among her latest patents are two notable innovations:

1. **Trivalent, Bispecific Antibodies** - This invention involves the production of trivalent, bispecific antibodies, along with pharmaceutical compositions containing these antibodies and their various uses.

2. **Bispecific Antibodies** - This patent details methods for producing bispecific antibodies, the pharmaceutical compositions that incorporate these antibodies, and their applications in medical treatment.

Career Highlights

Rebecca has worked with prominent companies in the biotech sector. Notably, she has been associated with Hoffmann-La Roche Inc. and Roche Glycart AG, where she has leveraged her expertise to advance research and development in antibody therapies. Her innovative approach has garnered recognition and solidified her reputation as a leading inventor in her field.

Collaborations

Throughout her career, Rebecca has collaborated with esteemed professionals, including her coworkers Ulrich Brinkmann and Christian Klein. These partnerships have been instrumental in driving her projects forward, enhancing the quality and impact of her inventions.

Conclusion

Rebecca Croasdale's contributions to biotechnology highlight her role as a pivotal inventor in the development of antibody therapies. Her continuous efforts in research and innovation underscore the importance of her work in improving therapeutic outcomes for patients worldwide. With her impressive patent portfolio and collaborations, Rebecca remains a notable figure in the realm of scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…